In line with this reasoning, it will be interesting to study whether NF‐κB inhibitors can down‐regulate MYB and inhibit the proliferation of CYLD‐defective cylindroma cells. Here, CYLD is linked to adnexal spiradenoma/cylindroma of a sweat gland.